Statement from FDA Commissioner Scott Gottlieb, M.D., on new strategies for addressing the crisis of opioid addiction

Press Announcements > Statement from FDA Commissioner Scott Gottlieb, M.D., on new strategies for addressing the crisis of opioid addiction through innovation in packaging, storage and disposal





Statement from FDA Commissioner Scott Gottlieb, M.D., on new strategies for addressing the crisis of opioid addiction through innovation in packaging, storage and disposal



One of my highest priorities as the Commissioner of the U.S. Food and Drug Administration is to take whatever steps we can to reduce the scope and human tragedy created by the epidemic of addiction to opioids. At the FDA, we’re especially focused on helping more patients struggling with current addiction receive appropriate care with proven treatments and reducing new cases of addiction. Lowering the rate of new addiction means also reducing overall exposure to opioids to prevent more people from becoming addicted to these drugs in the first place. In the setting of the President’s declaration of a national public health emergency related to the crisis, I’m reaffirming the FDA’s commitment to work across the full range of its authorities to address this epidemic. Continue reading.